Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 206.74M | $ 10.42M | 5.04% |
3/31/2025 | $ 175.97M | $ 4.66M | 2.65% |
12/31/2024 | $ 163.98M | $ 6M | 3.66% |
9/30/2024 | $ 139.42M | $ 4.78M | 3.43% |
6/30/2024 | $ 128.41M | $ 8.06M | 6.28% |
3/31/2024 | $ 126.52M | $ 6.58M | 5.2% |
12/31/2023 | $ 117.22M | $ 5.52M | 4.71% |
9/30/2023 | $ 115.32M | $ 6.11M | 5.3% |
6/30/2023 | $ 117.09M | $ 10.78M | 9.21% |
3/31/2023 | $ 123.61M | $ 11.08M | 8.96% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for RIGEL PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 2.05M ] / Assets [ $ 123.06M ]
(=) Inv. to Assets [ 1.67% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.09% |
median | 0% |
std | 11.11% |